loading

Kalvista Pharmaceuticals Inc (KALV) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
-
- - - -
Operating Expenses
28.16%
55.03
42.94 45.81 44.22 48.45
Operating Income/Loss
28.16%
-55.03
-42.94 -45.81 -44.22 -48.45
Nonoperating Income/Loss
247.43%
1.949
-1.322 3.543 3.772 3.806
Income/Loss From Continuing Operations Before Tax
19.92%
-53.08
-44.26 -42.27 -40.44 -44.65
Income Tax Expense/Benefit
120.13%
-0.855
4.247 - - -
Income/Loss From Continuing Operations After Tax
7.66%
-52.23
-48.51 -42.27 -40.44 -44.65
Net Income/Loss
7.66%
-52.23
-48.51 -42.27 -40.44 -44.65
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
97.85%
1.1305
52.64 46.70 46.23 2.2187
Diluted Average Shares
97.85%
1.1305
52.64 46.70 46.23 2.2187
Basic Earnings Per Share
7.61%
-0.99
-0.92 -0.91 -0.87 -1.07
Diluted Earnings Per Share
7.61%
-0.99
-0.92 -0.91 -0.87 -1.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
大文字化:     |  ボリューム (24 時間):